PranaX Corporation

About PranaX Corporation

PranaX is a company focused on leveraging the safety and evolving biology of exosomes to understand their regenerative properties. Their mission is to develop exosome-based products that deliver transformative benefits to retain or restore quality of life, envisioning a world where aging and degeneration are no longer barriers to a fulfilling life.

Products & Services

Exosome-based Products:Products developed using exosomes, small extracellular vesicles that play a critical role in intercellular communication and have potential in immune regulation, tissue regeneration, and neuronal communication, aimed at diagnostics, therapeutics, and understanding disease mechanisms.

Specialties

Exosome Technology Regenerative Wellness Biomedical Research

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 17000000 MR: - FA: $17 million FAN: 17000000	D: 2026-01-29 FD: 2026-01-29	1 investors

Series A Latest

2026-01-29

$17.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Steven J. Greco

FOUNDER, CHIEF STRATEGY OFFICER

LinkedIn (Pro only)

K

Kenneth Klein

CHIEF FINANCIAL OFFICER, FOUNDING TEAM MEMBER

LinkedIn (Pro only)

L

Lance Kelly

EXECUTIVE DIRECTOR OF COMMERCIALIZATION

LinkedIn (Pro only)

M

Michael Francis

MANUFACTURING AND DEVELOPMENT MANAGER

C

Christine Conley

HEAD OF QUALITY

View 2 more team members with Pro

Unlock Full Team Directory

Recent News